Physician profile
Bridget A Dauphin
NPI 1083604326
$1,490.09
in general payments reported to CMS, 2019-2025
18 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $83.78 · 2021: $155 · 2022: $172 · 2023: $309 · 2024: $409 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $426.79 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $319.71 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $220.47 | 2019-2024 | Jornay Pm |
| Corium, LLC | $111.33 | 2023-2025 | Azstarys |
| Pfizer INC. | $74.42 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.61 | 2020-2021 | |
| Glaxosmithkline, LLC. | $50.31 | 2021-2025 | Bexsero, Penmenvy |
| Kaleo, INC. | $38.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $37.08 | 2024-2025 | |
| Sanofi Pasteur INC. | $26.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.41 | 2025 | Jornay Pm |
| Shire North American Group INC | $18.33 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.46 | 2019 | |
| Alk-Abello, INC | $16.23 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $14.62 | 2024 | Flumist Quadrivalent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $14.05 | 2019 | |
| Merck Sharp & Dohme LLC | $13.63 | 2024 | Gardasil, Gardasil 9, Vaqta |
| Tris Pharma INC | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Dauphin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.